Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000259802

Medchemexpress LLC 3-fluoro-2-(pyrimidin-2-yl)phenyl-7-azabicyclo[2.2.1]heptan-7-yl methanone | 1628843-99-1 | 98.1% | C22H18F4N6O | 10MG
SDP

Catalog No. 5000259802
Encompass_Preferred

JNJ-54717793 is a research-stage, brain-penetrant selective orexin-1 receptor (OX1R) antagonist developed by Janssen Research & Development and characterized for preclinical pharmacology and behavioral models. It is described in peer-reviewed studies and is supplied to researchers for laboratory use.

  • selective orexin-1 receptor antagonist with high affinity.
  • brain-penetrant pharmacokinetic profile suitable for in vivo studies.
  • high reported purity (98.1%).
  • characterized in peer-reviewed pharmacology studies.
  • supplied for research use only, not for human or veterinary use.

Catalog No. 50-002-59802 Supplier Medchemexpress LLC Supplier No. HY13418810MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JNJ-54717793 is a research-stage, brain-penetrant selective orexin-1 receptor (OX1R) antagonist developed by Janssen Research & Development and characterized for preclinical pharmacology and behavioral models. It is described in peer-reviewed studies and is supplied to researchers for laboratory use.

  • selective orexin-1 receptor antagonist with high affinity.
  • brain-penetrant pharmacokinetic profile suitable for in vivo studies.
  • high reported purity (98.1%).
  • characterized in peer-reviewed pharmacology studies.
  • supplied for research use only, not for human or veterinary use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.